ESCRS - How to tackle astigmatism in each step of the surgical process ;
ESCRS - How to tackle astigmatism in each step of the surgical process ;

How to tackle astigmatism in each step of the surgical process

The ability to manage astigmatism might be the one factor that has had the most significant impact on surgical practices in the last decade

How to tackle astigmatism in each step of the surgical process
spalton-olsen-sastigmatism David J Spalton and Thomas Olsen chairing the ESCRS astigmatism management symposium The ESCRS Symposium, ‘Astigmatism Management in Cataract Surgery’, addressed what seems to be the single most pressing issue in anterior segment surgery today – how to tackle astigmatism in each step of the surgical process. “The ability to manage astigmatism might be the one factor that has had the most significant impact on our surgical practices in the last decade,” said Dr Graham Barrett, Australia, during his presentation. “There has been a complete paradigm shift regarding the level of acceptable residual astigmatism after cataract surgery,” he said. The symposium was chaired by David J Spalton and Thomas Olsen. “In the 1980s, 3.00D of astigmatism was acceptable. By the 1990s, 1.50D was considered a reasonable outcome. By the 2000s, 0.75D was the approximate limit, whereas currently, we’re really aiming for an even more accurate outcome of less than 0.5D,” said Dr Barrett. Dr Barrett finds that, when applied correctly, astigmatism prediction has become as accurate as spherical prediction. “I target even the most minimal residual cylinder, and I thus use toric intraocular lenses (IOLs) in 80% of astigmatic patients,” he said. Dr Warren Hill, USA, presented his views on intraoperative biometry, which, on average, he considers superior to preoperative calculations. “It provides a net solution, which includes the anterior cornea, posterior cornea and toric IOL, for the amount of toricity and its proper orientation,” he said. “Intraoperative aberrometry is very sensitive to different vergences in different meridians. These relatively small differences are less influenced by the effective lens position.” He said that this aspect allows the measurement of the astigmatic portion of the total refractive error to be more accurate than the spherical portion. “I see this technology allowing us to go to new places that we otherwise wouldn’t consider with toric calculators,” he concluded. Dr Sheraz Daya, UK, followed with advice on how to manage irregular astigmatism in cataract surgery. “Irregular astigmatism can make biometry especially difficult,” he said. “Simple dry eye can have a significant effect on keratometric cylinder, leading to readings of greater than 1.0D difference between two visits.” Dr Gerd Auffarth, Germany, addressed the challenge of marking the axis for the placement of toric IOLs. “Correct marking is crucial, as every degree of misaligment reduces the effect of the toric correction,” he said. Reviewing the many methods, from manual marking with an ink pen to femtosecond laser marking, Dr Auffarth concluded that, while most methods are very precise, the outcome is largely dependent on rotational stability of the toric IOL design and material. Dr Rudy Nuijts, The Netherlands, offered advice on managing the worst of all outcomes, the misaligned IOLs and severe astigmatic surprises. “The first step is to analyse which factors contribute to the unexpected outcome,” he said. “Is it surgically induced astigmatism, posterior astigmatism or IOL misalignment?” The decision to rotate or exchange a misaligned toric IOL depends on the amount of ametropia and residual astigmatism. “But for errors greater than 1.25D, IOL exchange or laser refractive touch-up is usually necessary,” he added. “However, surgical correction is not common in our database,” said Dr Nuijts. “Realignment is necessary in about 2% and exchange and laser touch-up in about 1%.” Overall, Dr Douglas Koch, USA, urged delegates to “be sceptical of measurements and be critical of your own data”.
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;